Many people use bottled water daily to stay hydrated and there are a lot of companies to choose from. So it is best to research the drinking water in question to see if the company is ethical as far as their source of water is really as stated, their packaging preferences are good for the environment, and ingredients such as vitamins, minerals, or pH balance are not added as an afterthought to a questionable water source.
One water company that has been very transparent in their business dealings, including, where they source their water is Waiakea. Founded by Ryan Emmons, Waiakea Water is unique as there is nothing added. It is bottled straight from the source at the Mauna Loa volcano. The concept of reducing a carbon footprint and leaving everything as nature intended is a big deal for Ryan Emmons and his employees at Waiakea. The company has even invested in technology to plastic bottles that degrade in a fraction of the time of regular plastic bottles. The company is the first Hawaiian bottling company to be labeled Carbon Neutral, meaning Waiakea Water does not impact the environment to be made.
Waiakea Water is naturally filtered through many layers of volcanic rock from the Mauna Loa volcano creating the perfect Waiakea Water pH level (8.2) needed to keep our bodies at optimal health. The Mauna Loa region receives high levels of rain daily which makes Waiakea Water is a highly renewable resource. After filtering through the volcanic rock, Waiakea Water offers the perfect blend of pH, silica and minerals to keep the body working at optimal levels, boasting hydration. The water also helps prevent acid reflux if drank on a daily basis.
There is another added benefit to buying Waiakea Water. The outstanding philanthropic work they perform. The sale of each liter of water benefits others as the company almost always gives away more water to those in need than it sells. Waiakea has also worked with organizations to provide wells for villages in remote areas of Africa. To read more about this naturally sweet and delicious water and the many benefits of supporting Waiakea, please click here.
Luiz Carlos Trabuco Cappi began his career like most professional in academia. The 56 year old bank executive and father of three has been a pillar in the finance world in Latin America for over three decades. He has always lived by his personal rule and key to success, “through persistence great things are achievable”. Mr. Carlos Trabuco Cappi didn’t go to school to study finance, but instead he has a degree from the University of Sao Paulo. Carlo has a degree in Faculty of Philosophy, Sciences and Letters. Luiz Carlos Trabuco Cappi attended the School of Sociology and Politics, Sao Paulo.
Luiz Carlos Trabuco Cappi began his career at Banco Bradesco in 1969 in his birth city of Marilia. Marilia is also the home of the very first branch of Banco Bradesco that opened over 70 years ago in 1943. Most employees of Banco Bradesco stay with the company their entire professional career and Mr. Cappi is no exception. Beginning his career in 1969 as a clerk, Luiz would eventually become only the fourth President in the 70 year history of Banco Bradesco. Banco Bradesco is currently one the largest banking and financial services bank in Latin America, and has been a pivotal player in many sectors in Latin America’s largest economy.
Mr. Trabuco Cappi first took on the role as a clerk, before relocating to Sau Paulo. In 1984 he became the Director of Marketing. During Mr. Cappi’s time as Marketing Director, he was responsible for forging an opened culture with Banco Bradesco and the media. Luiz recognized the importance of gaining and maintaining the trust of the public, a task impossible without the media. In 1998 he would become the Managing Director Executive. By the time he was 47 in 1999, Mr. Cappi would be appointed Vice President of Banco Bradesco. Eventually he would go on to become the Chief Executive of Banco Bradesco, a position he held for six years until 2005. During his time as chief executive, Luiz Carlos Trabuco Cappi would also become the leader of Banco Bradesco Seguros. Banco Bradesco Seguros is the insurance company under the corporate umbrella of Bradesco. While leading Bradesco Seguros, Luiz would increase the market share of insurance premiums to about 1/4th of the total insurance market share in Brazil, which resulted in an increase of Banco Bradesco’s profits from 26%-35%. Luiz consolidated the leadership within Bradesco Seguros all while doubling the size of the company. It was during his time as the leader of Bradesco Seguros, and the success the company experienced is what solidified his inevitable rise to become President of the banking giant by 2009. In 2015, Luiz Carlos Trabuco Cappi was named Entrepreneur of the year by Money Magazine. It was during Luiz’s time as president Banco Bradesco led the company in the record breaking acquisition of HSBC. The deal for HSBC was for $ 5.2 billion, the largest of the year.
Learn more about Luiz Carlos Trabuco Cappi: http://www1.folha.uol.com.br/mercado/2017/10/1926243-proximo-presidente-do-bradesco-saira-da-diretoria-do-banco-diz-trabuco.shtml
Clay Siegall is the founder of the Seattle-based firm called Seattle Genetics. He studied in Maryland University where he undertook a B.S. in zoology and held a Ph.D. in genetics from the University of George Washington. Seattle Genetics specializes in therapy for diseases that have not shown any improvement in the past decades.
Seattle Genetics aims at improving scientific inventions by carrying out intensive research on drugs to help patients suffering from cancer. Dr. Siegall is a scientist by profession whose focus is on cancer therapies. He has led Seattle Genetics since 1998 with his leadership building an antibody-drug conjugate (ADC) to treat cancer.
Recently, more people get diagnosed with cancer hence using radiation and chemotherapy methods to treat the disease. However, human genetics is changing thus there is a dire need to improve the treatment of the disease. Dr. Clay B. Siegall has devoted to helping companies research an effective medicine for cancer. Earlier cancer testing is vital because it identifies the effective treatment of the disease.
DNA tests through genome sequencing identify errors in cancerous cells and healthy cells. In such a case, we use genomic medicine to gear protection to the genetic code of the patient. Genomic medicine shows an exceptional promise towards cancer treatment.
Genome sequencing is essential in the cancer therapy since it detects the active treatment. Also, it saves doctors time of trying different medication with a risk that a patient may get the wrong medication. In fact, it keeps the doctors’ performance with a possible clue to cancer treatment.
In other news, researchers from the University of England have come up with a way to identify bladder cancer. Using the urine test, a doctor can detect crude protein, TERT, in the urine. Recent analysis shows that the test is 80 percent accurate as compared to cytology testing which was rated 34 percent accurate.
Summing up, Netherlands has come up with an exciting and more promising way to diagnose prostate cancer. Unlike in the past years where the diagnoses would take months to get an accurate treatment, this method will save lives if detected in early stages.